Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)

NCT02837198 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: FYU-981
DRUG: Topiroxostat

Sponsor

Fuji Yakuhin Co., Ltd.